SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-18-002964
Filing Date
2018-04-19
Accepted
2018-04-19 16:04:31
Documents
3
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2234710zpre14a.htm PRE 14A 724091
2 G29172BII001.GIF g29172bii001.gif GRAPHIC 290078
3 G29172BII002.GIF g29172bii002.gif GRAPHIC 163952
  Complete submission text file 0001047469-18-002964.txt   1350728
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-15006 | Film No.: 18763827
SIC: 2835 In Vitro & In Vivo Diagnostic Substances